Package 23155-895-06

{"route": ["ORAL"], "spl_id": "c6498e0a-7dbe-4132-897b-a2721fb2190c", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "upc": ["0323155895063", "0323155894066"], "unii": ["0H73WJJ391"], "rxcui": ["205315", "205316"], "spl_set_id": ["1730870d-e661-41f9-bd0d-d8daaf087819"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE in 1 BOTTLE (23155-895-06)", "package_ndc": "23155-895-06", "marketing_end_date": "20260228", "marketing_start_date": "20240216"}], "brand_name": "TOPIRAMATE", "product_id": "23155-895_c6498e0a-7dbe-4132-897b-a2721fb2190c", "dosage_form": "CAPSULE", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "23155-895", "generic_name": "topiramate spinkle", "labeler_name": "Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TOPIRAMATE", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "25 mg/1"}], "application_number": "ANDA078418", "marketing_category": "ANDA", "marketing_end_date": "20260228", "marketing_start_date": "20240216"}